C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/36 (2006.01) A61K 39/395 (2006.01) A61P 7/02 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2747519
Disclosed herein are monoclonal antibodies specific for factor XI (fXI) that prevent activation of fXI by factor XIIa (fXIIa). The monoclonal antibodies are universal fXI antibodies, capable of binding all mammalian species tested. The anti-fXI monoclonal antibodies prolong clotting time in mammalian plasmas. Moreover, administration of the fXI monoclonal antibodies disclosed herein results in inhibition of thrombosis without altering hemostasis in animal models of thrombosis. Thus, pro-vided herein are monoclonal antibodies specific for fXI that block activation of fXI by fXIIa, compositions and immunoconjugates comprising such antibodies and their methods of use.
L'invention porte sur des anticorps monoclonaux, spécifiques au facteur XI (fXI), qui empêchent l'activation de fXI par le facteur XIIa (fXIIa). Les anticorps monoclonaux sont des anticorps fXI universels, capables de se lier à toutes les espèces de mammifère testées. Les anticorps monoclonaux anti-fXI prolongent le temps de coagulation dans des plasmas de mammifère. De plus, l'administration des anticorps monoclonaux fXI décrits ici conduit à l'inhibition de la thrombose, sans altérer l'hémostase chez des modèles animaux de thrombose. Ainsi, l'invention porte sur des anticorps monoclonaux, spécifiques au facteur fXI, qui bloquent l'activation de fXI par fXIIa, sur des compositions et des immuno-conjugués renfermant de tels anticorps et sur leurs procédés d'utilisation.
Gailani David
Gruber Andras
Tucker Erik I.
Goudreau Gage Dubuc
Oregon Health & Science University
Vanderbilt University
LandOfFree
Anti-fxi antibodies and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-fxi antibodies and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-fxi antibodies and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1813206